Pharma investor’s award against Ecuador upheld
A Merck facility in San Francisco (Credit: Shutterstock/Tada Images)
A Dutch court has upheld a US pharmaceuticals company’s €44 million investment treaty award against Ecuador, dismissing arguments that the arbitrators took on the role of a final appeal court when they held the state liable for a denial of justice.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now